O
MED icon

OppenheimerFunds’s Medifast MED Stock Holding History

OppenheimerFunds’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$284K Buy
2,228
+452
+25% +$57.3K ﹤0.01% 1573
2018
Q4 		$222K Buy
1,776
+596
+51% +$102K ﹤0.01% 1693
2018
Q3 		$261K Sell
1,180
-407
-26% -$82.5K ﹤0.01% 1703
2018
Q2 		$254K Sell
1,587
-836
-35% -$107K ﹤0.01% 1690
2018
Q1 		$226K Sell
2,423
-545
-18% -$40.7K ﹤0.01% 1697
2017
Q4 		$207K Sell
2,968
-746
-20% -$49.5K ﹤0.01% 1805
2017
Q3 		$221K Sell
3,714
-1,248
-25% -$62.1K ﹤0.01% 1793
2017
Q2 		$206K Buy
4,962
+49
+1% +$2.13K ﹤0.01% 1813
2017
Q1 		$218K Buy
+4,913
New +$211K ﹤0.01% 1807

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JIM
Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return
HCM
Hoplite Capital Management New York $15.1M AUM 27.41% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

OppenheimerFunds's MED Position: Q1 2019 in Review

OppenheimerFunds increased its Medifast (MED) stake by 25% in Q1 2019, buying an estimated $57.3K and bringing the position to 2,228 shares worth $284K. The position accounts for ﹤0.01% of the portfolio, ranked #1573.

OppenheimerFunds first reported a position in MED in Q1 2017 and has held it in 9 quarters since. 246 funds tracked by Wall St. Rank hold MED as of Q1 2019.

  • OppenheimerFunds held 2,228 shares of Medifast worth $284K as of Q1 2019.
  • OppenheimerFunds bought 452 Medifast shares in Q1 2019, an estimated $57.3K.
  • Medifast made up ﹤0.01% of OppenheimerFunds's portfolio in Q1 2019, its #1573 holding.
  • OppenheimerFunds first reported a position in Medifast in Q1 2017 and has held it in 9 quarters since.
  • 246 funds tracked by Wall St. Rank held Medifast as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.